002437 logo

HARBIN GLORIA PHARMACEUTICALS Co., LTD Stock Price

SZSE:002437 Community·CN¥7.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002437 Share Price Performance

CN¥3.46
0.99 (40.08%)
CN¥3.46
0.99 (40.08%)
Price CN¥3.46

002437 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet and good value.

1 Risk
3 Rewards

HARBIN GLORIA PHARMACEUTICALS Co., LTD Key Details

CN¥2.2b

Revenue

CN¥1.2b

Cost of Revenue

CN¥1.1b

Gross Profit

CN¥794.1m

Other Expenses

CN¥293.0m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.13
48.35%
13.03%
3.2%
View Full Analysis

About 002437

Founded
2000
Employees
2703
CEO
Leifeng Guo
WebsiteView website
www.gloria.cc

HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China.

Recent 002437 News & Updates

Recent updates

No updates